Which data does physiologically based pharmacokinetic (PBPK) modeling use to predict drug distribution across organs?

Which data does physiologically based pharmacokinetic (PBPK) modeling use to predict drug distribution across organs?

• A. Tissue-specific partition coefficients, tissue perfusion rates, and binding
• B. Only tissue-specific partition coefficients
• C. Only systemic clearance rates
• D. Only protein binding data

Answer: (A)

In PBPK modeling, predicting how a drug distributes to different organs relies on parameters that capture both how quickly the drug reaches tissues and how it partitions once it arrives. Tissue-specific partition coefficients (Kp) describe how the drug distributes between blood and each tissue, essentially setting the extent of it that will reside in the tissue relative to plasma. Tissue perfusion rates, or organ blood flows, determine how fast the drug is delivered to each tissue, driving the kinetics of distribution. Binding to tissue components accounts for drug sequestration within tissues, reducing the freely circulating fraction and modifying the apparent distribution volume. Using all three together lets the model simulate both the amount of drug that ends up in each organ and how rapidly it gets there. Relying on only partition coefficients would miss the delivery rate; relying on only perfusion would miss how much actually partitions into the tissue; relying on only binding would miss how the drug distributes between blood and tissue and how fast it reaches the tissues. PBPK thus integrates these physiological and physicochemical factors to predict organ-by-organ distribution and concentration-time profiles.

In PBPK modeling, predicting how a drug distributes to different organs relies on parameters that capture both how quickly the drug reaches tissues and how it partitions once it arrives. Tissue-specific partition coefficients (Kp) describe how the drug distributes between blood and each tissue, essentially setting the extent of it that will reside in the tissue relative to plasma. Tissue perfusion rates, or organ blood flows, determine how fast the drug is delivered to each tissue, driving the kinetics of distribution. Binding to tissue components accounts for drug sequestration within tissues, reducing the freely circulating fraction and modifying the apparent distribution volume.

Using all three together lets the model simulate both the amount of drug that ends up in each organ and how rapidly it gets there. Relying on only partition coefficients would miss the delivery rate; relying on only perfusion would miss how much actually partitions into the tissue; relying on only binding would miss how the drug distributes between blood and tissue and how fast it reaches the tissues. PBPK thus integrates these physiological and physicochemical factors to predict organ-by-organ distribution and concentration-time profiles.